Prescient Therapeutics Limited (PTX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -7.39 Million | -6.19 Million | -4.31 Million | -3.97 Million | -2.31 Million | -4.19 Million |
| Net Income | -8.23 Million | -7 Million | -5.11 Million | -4.14 Million | -3.32 Million | -3.79 Million |
| Depreciation & Amortization | 717.00 | 2088.00 | 1403.00 | 474.00 | 904.00 | 1338.00 |
| Deferred income taxes | - | -166.22 Thousand | -524.32 Thousand | -1.05 Million | 164.34 Thousand | -184.49 Thousand |
| Stock-based compensation | 211.73 Thousand | 463.65 Thousand | 883.76 Thousand | 647.16 Thousand | 188.41 Thousand | 256.17 Thousand |
| Change in working capital | -1.11 Million | 342.02 Thousand | -25.52 Thousand | -505.87 Thousand | 849.31 Thousand | -71.67 Thousand |
| Other non-cash items | 3.34 Million | 171.95 Thousand | 469.19 Thousand | 1.09 Million | -198.96 Thousand | -399.57 Thousand |
| Investing Cash Flow | 12 Million | -16 Million | -4429.00 | -2314.00 | - | - |
| Investments in PPE | -3.00 | - | -4429.00 | -2314.00 | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -16 Million | - | - | - | - |
| Sales/Maturities of investments | 12 Million | - | - | - | - | - |
| Other Investing Activities | 12 Million | -16 Million | - | - | - | - |
| Financing Cash Flow | 18.15 Thousand | 15.82 Million | 428.29 Thousand | 12.74 Million | - | 8.36 Million |
| Debt repayment | - | - | -165.82 Thousand | -8949.00 | - | -56.04 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -836.55 Thousand | - | -699.48 Thousand |
| Common Stock Issuance | 18.15 Thousand | 15.82 Million | 594.12 Thousand | 12.74 Million | - | 8.42 Million |
| Other Financing Activities | 18.15 Thousand | -697.81 Thousand | 428.29 Thousand | 12.76 Million | - | 8.36 Million |
| Accounts receivables | -1.34 Million | -858.67 Thousand | -24 Thousand | -23.87 Thousand | 87.35 Thousand | -71.67 Thousand |
| Accounts payables | -56.2 Thousand | 1.16 Million | 386.25 Thousand | -385.22 Thousand | 267.21 Thousand | 144.94 Thousand |
| Inventory | - | - | - | - | - | 601.55 Thousand |
| Other working capital | 285.79 Thousand | 40.42 Thousand | -387.77 Thousand | -96.77 Thousand | 494.74 Thousand | -746.49 Thousand |
| Cash at beginning of period | 5.89 Million | 12.26 Million | 16.09 Million | 7.35 Million | 9.65 Million | 5.48 Million |
| Cash at end of period | 10.49 Million | 5.89 Million | 12.26 Million | 16.09 Million | 7.35 Million | 9.63 Million |
| Capital Expenditure | -3.00 | - | -4429.00 | -2314.00 | - | - |
| Effect of forex changes on cash | -22.49 Thousand | -5734.00 | 55.12 Thousand | -36.94 Thousand | 34.62 Thousand | -17.47 Thousand |
| Net cash flow / Change in cash | 4.59 Million | -6.36 Million | -3.83 Million | 8.74 Million | -2.3 Million | 4.15 Million |
| Free Cash Flow | -7.39 Million | -6.19 Million | -4.31 Million | -3.97 Million | -2.31 Million | -4.19 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.61 Million | -8.23 Million | -3.61 Million | -4.12 Million | -7 Million | -2.87 Million |
| Depreciation & Amortization | 717.00 | 717.00 | - | 2088.00 | 2088.00 | - |
| Deferred income taxes | - | - | - | -77 Thousand | -166.22 Thousand | - |
| Stock-based compensation | 76.08 Thousand | - | 135.65 Thousand | 205.98 Thousand | 463.65 Thousand | 257.66 Thousand |
| Change in working capital | -1.05 Million | -1.11 Million | - | -818.25 Thousand | 342.02 Thousand | - |
| Other non-cash items | 1.68 Million | 3.34 Million | -902.00 | -58.3 Thousand | 171.95 Thousand | 614.13 Thousand |
| Investing Cash Flow | 8 Million | 12 Million | 4 Million | -16 Million | -16 Million | 12.26 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | -16 Million | -16 Million | - |
| Sales/Maturities of investments | - | 12 Million | 4 Million | - | - | - |
| Other Investing Activities | 8 Million | - | 4 Million | -16 Million | -16 Million | - |
| Financing Cash Flow | - | 18.15 Thousand | 18.15 Thousand | 5.13 Million | 15.82 Million | 10.69 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 18.15 Thousand | 18.15 Thousand | 5.13 Million | 15.82 Million | 10.69 Million |
| Other Financing Activities | - | - | 18.15 Thousand | 5.13 Million | -697.81 Thousand | 10.69 Million |
| Accounts receivables | 3126.00 | -1.34 Million | - | -131.06 Thousand | -858.67 Thousand | - |
| Accounts payables | - | -56.2 Thousand | - | - | 1.16 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.05 Million | 285.79 Thousand | - | -687.19 Thousand | 40.42 Thousand | - |
| Cash at beginning of period | 6.41 Million | 5.89 Million | 5.89 Million | 20.95 Million | 12.26 Million | 12.26 Million |
| Cash at end of period | 10.49 Million | 10.49 Million | 6.41 Million | 5.89 Million | 5.89 Million | 20.95 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -11.69 Thousand | -22.49 Thousand | -10.79 Thousand | -7915.00 | -5734.00 | 2181.00 |
| Net cash flow / Change in cash | 4.07 Million | 4.59 Million | 522.68 Thousand | -15.05 Million | -6.36 Million | 8.68 Million |
| Free Cash Flow | -3.91 Million | -7.39 Million | -3.48 Million | -4.18 Million | -6.19 Million | -2 Million |
CENTR
DKSH
5297
SAWAD
WEZ
300515